Atıf Formatları
Pulmonary aspergillosis in a patient with COPD due to PEG-interferon and ribavirin therapy for chronic hepatitis C
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Ö. ERSOY Et Al. , "Pulmonary aspergillosis in a patient with COPD due to PEG-interferon and ribavirin therapy for chronic hepatitis C," Case Reports in Clinical Medicine , vol.2, no.1, pp.70-75, 2013

ERSOY, Ö. Et Al. 2013. Pulmonary aspergillosis in a patient with COPD due to PEG-interferon and ribavirin therapy for chronic hepatitis C. Case Reports in Clinical Medicine , vol.2, no.1 , 70-75.

ERSOY, Ö., VARDARELİ, N. E., Seyhmus, G., & TOZUN, N., (2013). Pulmonary aspergillosis in a patient with COPD due to PEG-interferon and ribavirin therapy for chronic hepatitis C. Case Reports in Clinical Medicine , vol.2, no.1, 70-75.

ERSOY, ÖZDAL Et Al. "Pulmonary aspergillosis in a patient with COPD due to PEG-interferon and ribavirin therapy for chronic hepatitis C," Case Reports in Clinical Medicine , vol.2, no.1, 70-75, 2013

ERSOY, ÖZDAL Et Al. "Pulmonary aspergillosis in a patient with COPD due to PEG-interferon and ribavirin therapy for chronic hepatitis C." Case Reports in Clinical Medicine , vol.2, no.1, pp.70-75, 2013

ERSOY, Ö. Et Al. (2013) . "Pulmonary aspergillosis in a patient with COPD due to PEG-interferon and ribavirin therapy for chronic hepatitis C." Case Reports in Clinical Medicine , vol.2, no.1, pp.70-75.

@article{article, author={ÖZDAL ERSOY Et Al. }, title={Pulmonary aspergillosis in a patient with COPD due to PEG-interferon and ribavirin therapy for chronic hepatitis C}, journal={Case Reports in Clinical Medicine}, year=2013, pages={70-75} }